Lemaitre Vascular (LMAT) Assets Average (2011 - 2026)
Lemaitre Vascular's (LMAT) quarterly Assets Average came in at $635.0 million in Q2 2026, up 12.04% year-over-year from $566.8 million in Q2 2025, and up 2.0% quarter-over-quarter from $622.6 million in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Assets Average (2011 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Assets Average for 16 consecutive years, with $635.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Assets Average rose 12.04% year-over-year to $635.0 million in Q2 2026; TTM through Jun 2026 was $635.0 million, a 12.04% increase from a year earlier, with the FY2025 full-year figure at $583.8 million, up 29.93% from the prior year.
- Assets Average was $635.0 million for Q2 2026 at Lemaitre Vascular, up from $622.6 million in the prior quarter.
- Over five years, Assets Average peaked at $635.0 million in Q2 2026 and troughed at $292.6 million in Q1 2022.
- A 5-year average of $423.1 million and a median of $354.4 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average climbed 5.19% in 2022 and surged 58.85% in 2025, its largest moves.
- Over 5 years, Assets Average stood at $306.3 million in 2022, then increased by 11.15% to $340.4 million in 2023, then soared by 36.44% to $464.4 million in 2024, then jumped by 30.67% to $606.9 million in 2025, then climbed by 4.64% to $635.0 million in 2026.
- The last three Assets Average figures came in at $635.0 million (Q2 2026), $622.6 million (Q1 2026), and $606.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 20.49 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 93.17 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 47.11 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 44.78 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 13.59 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 31.36 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 6.54 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 635.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 635.04 Mn |
| Mar 31, 2026 | 622.61 Mn |
| Dec 31, 2025 | 606.88 Mn |
| Sep 30, 2025 | 587.83 Mn |
| Jun 30, 2025 | 566.80 Mn |
| Mar 31, 2025 | 553.91 Mn |
| Dec 31, 2024 | 464.42 Mn |
| Sep 30, 2024 | 370.05 Mn |
| Jun 30, 2024 | 358.52 Mn |
| Mar 31, 2024 | 350.37 Mn |
| Dec 31, 2023 | 340.40 Mn |
| Sep 30, 2023 | 330.24 Mn |
| Jun 30, 2023 | 320.67 Mn |
| Mar 31, 2023 | 312.67 Mn |
| Dec 31, 2022 | 306.26 Mn |
| Sep 30, 2022 | 300.74 Mn |
| Jun 30, 2022 | 295.94 Mn |
| Mar 31, 2022 | 292.63 Mn |
| Dec 31, 2021 | 291.14 Mn |
| Sep 30, 2021 | 267.99 Mn |